世界の化膿性汗腺炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hidradenitis Suppurativa Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4312 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User	￥819,000 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、化膿性汗腺炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（投薬、手術、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・化膿性汗腺炎治療の市場動向 ・企業の競争状況、市場シェア ・化膿性汗腺炎治療の種類別市場規模と予測2016-2027（投薬、手術、その他） ・化膿性汗腺炎治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・化膿性汗腺炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・化膿性汗腺炎治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・化膿性汗腺炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・化膿性汗腺炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・化膿性汗腺炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Merck、Pfizer、AstraZeneca、GlaxoSmithKline、Perrigo、Sun Pharma、Almirall、Bausch Health、Johnson & Johnson） ・結論

Hidradenitis suppurativa (HS) is a painful, long-term skin condition that causes abscesses and scarring on the skin.

Market Analysis and Insights: Global Hidradenitis Suppurativa Therapeutics Market
The global Hidradenitis Suppurativa Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hidradenitis Suppurativa Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hidradenitis Suppurativa Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hidradenitis Suppurativa Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hidradenitis Suppurativa Therapeutics market.

Global Hidradenitis Suppurativa Therapeutics Scope and Market Size
Hidradenitis Suppurativa Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hidradenitis Suppurativa Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medications
Surgery
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Merck
Pfizer
AstraZeneca
GlaxoSmithKline
Perrigo
Sun Pharma
Almirall
Bausch Health
Johnson & Johnson

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hidradenitis Suppurativa Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medications
1.2.3 Surgery
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hidradenitis Suppurativa Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hidradenitis Suppurativa Therapeutics Market Perspective (2016-2027)
2.2 Hidradenitis Suppurativa Therapeutics Growth Trends by Regions
2.2.1 Hidradenitis Suppurativa Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hidradenitis Suppurativa Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Hidradenitis Suppurativa Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Hidradenitis Suppurativa Therapeutics Industry Dynamic
2.3.1 Hidradenitis Suppurativa Therapeutics Market Trends
2.3.2 Hidradenitis Suppurativa Therapeutics Market Drivers
2.3.3 Hidradenitis Suppurativa Therapeutics Market Challenges
2.3.4 Hidradenitis Suppurativa Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hidradenitis Suppurativa Therapeutics Players by Revenue
3.1.1 Global Top Hidradenitis Suppurativa Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Hidradenitis Suppurativa Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Hidradenitis Suppurativa Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hidradenitis Suppurativa Therapeutics Revenue
3.4 Global Hidradenitis Suppurativa Therapeutics Market Concentration Ratio
3.4.1 Global Hidradenitis Suppurativa Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hidradenitis Suppurativa Therapeutics Revenue in 2020
3.5 Hidradenitis Suppurativa Therapeutics Key Players Head office and Area Served
3.6 Key Players Hidradenitis Suppurativa Therapeutics Product Solution and Service
3.7 Date of Enter into Hidradenitis Suppurativa Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hidradenitis Suppurativa Therapeutics Breakdown Data by Type
4.1 Global Hidradenitis Suppurativa Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Hidradenitis Suppurativa Therapeutics Forecasted Market Size by Type (2022-2027)

5 Hidradenitis Suppurativa Therapeutics Breakdown Data by Application
5.1 Global Hidradenitis Suppurativa Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Hidradenitis Suppurativa Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hidradenitis Suppurativa Therapeutics Market Size (2016-2027)
6.2 North America Hidradenitis Suppurativa Therapeutics Market Size by Type
6.2.1 North America Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Hidradenitis Suppurativa Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2027)
6.3 North America Hidradenitis Suppurativa Therapeutics Market Size by Application
6.3.1 North America Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Hidradenitis Suppurativa Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2027)
6.4 North America Hidradenitis Suppurativa Therapeutics Market Size by Country
6.4.1 North America Hidradenitis Suppurativa Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Hidradenitis Suppurativa Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hidradenitis Suppurativa Therapeutics Market Size (2016-2027)
7.2 Europe Hidradenitis Suppurativa Therapeutics Market Size by Type
7.2.1 Europe Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Hidradenitis Suppurativa Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2027)
7.3 Europe Hidradenitis Suppurativa Therapeutics Market Size by Application
7.3.1 Europe Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Hidradenitis Suppurativa Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2027)
7.4 Europe Hidradenitis Suppurativa Therapeutics Market Size by Country
7.4.1 Europe Hidradenitis Suppurativa Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Hidradenitis Suppurativa Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Type
8.2.1 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Application
8.3.1 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Region
8.4.1 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hidradenitis Suppurativa Therapeutics Market Size (2016-2027)
9.2 Latin America Hidradenitis Suppurativa Therapeutics Market Size by Type
9.2.1 Latin America Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Hidradenitis Suppurativa Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Hidradenitis Suppurativa Therapeutics Market Size by Application
9.3.1 Latin America Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Hidradenitis Suppurativa Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Hidradenitis Suppurativa Therapeutics Market Size by Country
9.4.1 Latin America Hidradenitis Suppurativa Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Hidradenitis Suppurativa Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Type
10.2.1 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Application
10.3.1 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Country
10.4.1 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Hidradenitis Suppurativa Therapeutics Introduction
11.1.4 AbbVie Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Hidradenitis Suppurativa Therapeutics Introduction
11.2.4 Merck Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Hidradenitis Suppurativa Therapeutics Introduction
11.3.4 Pfizer Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Hidradenitis Suppurativa Therapeutics Introduction
11.4.4 AstraZeneca Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Hidradenitis Suppurativa Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Perrigo
11.6.1 Perrigo Company Details
11.6.2 Perrigo Business Overview
11.6.3 Perrigo Hidradenitis Suppurativa Therapeutics Introduction
11.6.4 Perrigo Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
11.6.5 Perrigo Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Details
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Hidradenitis Suppurativa Therapeutics Introduction
11.7.4 Sun Pharma Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
11.7.5 Sun Pharma Recent Development
11.8 Almirall
11.8.1 Almirall Company Details
11.8.2 Almirall Business Overview
11.8.3 Almirall Hidradenitis Suppurativa Therapeutics Introduction
11.8.4 Almirall Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
11.8.5 Almirall Recent Development
11.9 Bausch Health
11.9.1 Bausch Health Company Details
11.9.2 Bausch Health Business Overview
11.9.3 Bausch Health Hidradenitis Suppurativa Therapeutics Introduction
11.9.4 Bausch Health Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
11.9.5 Bausch Health Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Hidradenitis Suppurativa Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hidradenitis Suppurativa Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medications
Table 3. Key Players of Surgery
Table 4. Key Players of Others
Table 5. Global Hidradenitis Suppurativa Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hidradenitis Suppurativa Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hidradenitis Suppurativa Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hidradenitis Suppurativa Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Hidradenitis Suppurativa Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hidradenitis Suppurativa Therapeutics Market Share by Regions (2022-2027)
Table 11. Hidradenitis Suppurativa Therapeutics Market Trends
Table 12. Hidradenitis Suppurativa Therapeutics Market Drivers
Table 13. Hidradenitis Suppurativa Therapeutics Market Challenges
Table 14. Hidradenitis Suppurativa Therapeutics Market Restraints
Table 15. Global Hidradenitis Suppurativa Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hidradenitis Suppurativa Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Hidradenitis Suppurativa Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hidradenitis Suppurativa Therapeutics as of 2020)
Table 18. Ranking of Global Top Hidradenitis Suppurativa Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hidradenitis Suppurativa Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hidradenitis Suppurativa Therapeutics Product Solution and Service
Table 22. Date of Enter into Hidradenitis Suppurativa Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hidradenitis Suppurativa Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Hidradenitis Suppurativa Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hidradenitis Suppurativa Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hidradenitis Suppurativa Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hidradenitis Suppurativa Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Hidradenitis Suppurativa Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hidradenitis Suppurativa Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hidradenitis Suppurativa Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hidradenitis Suppurativa Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hidradenitis Suppurativa Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hidradenitis Suppurativa Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hidradenitis Suppurativa Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hidradenitis Suppurativa Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hidradenitis Suppurativa Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hidradenitis Suppurativa Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hidradenitis Suppurativa Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hidradenitis Suppurativa Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hidradenitis Suppurativa Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hidradenitis Suppurativa Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. AbbVie Company Details
Table 63. AbbVie Business Overview
Table 64. AbbVie Hidradenitis Suppurativa Therapeutics Product
Table 65. AbbVie Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021) & (US$ Million)
Table 66. AbbVie Recent Development
Table 67. Merck Company Details
Table 68. Merck Business Overview
Table 69. Merck Hidradenitis Suppurativa Therapeutics Product
Table 70. Merck Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Hidradenitis Suppurativa Therapeutics Product
Table 75. Pfizer Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. AstraZeneca Company Details
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Hidradenitis Suppurativa Therapeutics Product
Table 80. AstraZeneca Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. GlaxoSmithKline Company Details
Table 83. GlaxoSmithKline Business Overview
Table 84. GlaxoSmithKline Hidradenitis Suppurativa Therapeutics Product
Table 85. GlaxoSmithKline Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021) & (US$ Million)
Table 86. GlaxoSmithKline Recent Development
Table 87. Perrigo Company Details
Table 88. Perrigo Business Overview
Table 89. Perrigo Hidradenitis Suppurativa Therapeutics Product
Table 90. Perrigo Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Perrigo Recent Development
Table 92. Sun Pharma Company Details
Table 93. Sun Pharma Business Overview
Table 94. Sun Pharma Hidradenitis Suppurativa Therapeutics Product
Table 95. Sun Pharma Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Sun Pharma Recent Development
Table 97. Almirall Company Details
Table 98. Almirall Business Overview
Table 99. Almirall Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Almirall Recent Development
Table 101. Bausch Health Company Details
Table 102. Bausch Health Business Overview
Table 103. Bausch Health Hidradenitis Suppurativa Therapeutics Product
Table 104. Bausch Health Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Bausch Health Recent Development
Table 106. Johnson & Johnson Company Details
Table 107. Johnson & Johnson Business Overview
Table 108. Johnson & Johnson Hidradenitis Suppurativa Therapeutics Product
Table 109. Johnson & Johnson Revenue in Hidradenitis Suppurativa Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Johnson & Johnson Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hidradenitis Suppurativa Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Medications Features
Figure 3. Surgery Features
Figure 4. Others Features
Figure 5. Global Hidradenitis Suppurativa Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Hidradenitis Suppurativa Therapeutics Report Years Considered
Figure 10. Global Hidradenitis Suppurativa Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Hidradenitis Suppurativa Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Hidradenitis Suppurativa Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Hidradenitis Suppurativa Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Hidradenitis Suppurativa Therapeutics Market Share by Players in 2020
Figure 15. Global Top Hidradenitis Suppurativa Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hidradenitis Suppurativa Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Hidradenitis Suppurativa Therapeutics Revenue in 2020
Figure 17. Global Hidradenitis Suppurativa Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Hidradenitis Suppurativa Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Hidradenitis Suppurativa Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Hidradenitis Suppurativa Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Hidradenitis Suppurativa Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hidradenitis Suppurativa Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Hidradenitis Suppurativa Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Hidradenitis Suppurativa Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Hidradenitis Suppurativa Therapeutics Market Share by Region (2016-2027)
Figure 39. China Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hidradenitis Suppurativa Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Hidradenitis Suppurativa Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Hidradenitis Suppurativa Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Hidradenitis Suppurativa Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Hidradenitis Suppurativa Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AbbVie Revenue Growth Rate in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
Figure 59. Merck Revenue Growth Rate in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
Figure 63. Perrigo Revenue Growth Rate in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
Figure 64. Sun Pharma Revenue Growth Rate in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
Figure 65. Almirall Revenue Growth Rate in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
Figure 66. Bausch Health Revenue Growth Rate in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in Hidradenitis Suppurativa Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---